We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Engility Holdings, Inc. | NYSE:EGL | NYSE | Ordinary Share |
| Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 29.10 | 0.00 | 01:00:00 |
From May 2019 to May 2024
By Josh Beckerman
NeoGenomics Inc. (NEO) shares rose 8.4% to $14.25 as S&P Dow Jones Indices said the genetic testing company will join the S&P SmallCap 600.
NeoGenomics will join the index before trading opens on Jan. 14, replacing government-services provider Engility Holdings Inc. (EGL). In September, Science Applications International Corp. (SAIC) agreed to buy Engility in a stock deal originally valued at $1.5 billion.
Last week, Needham & Co. initiated coverage of NeoGenomics with a Buy rating and a $14 price target.
Write to Josh Beckerman at josh.beckerman@wsj.com
(END) Dow Jones Newswires
January 08, 2019 20:01 ET (01:01 GMT)
Copyright (c) 2019 Dow Jones & Company, Inc.
1 Year Engility Holdings, Inc. Chart |
1 Month Engility Holdings, Inc. Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
